Ending radioactive water leaks along with groundwater and ocean contamination at the wrecked Fukushima nuclear plant in Japan may take more than five years, according to a report by a government advisory body.
Retina Institute Japan K.K., which is employing Nobel Prize-winning stem-cell technology to treat eye diseases, plans to sell a stake in itself to a group of Japanese companies next month ahead of a possible initial public offering in five years.
John B. Gurdon transferred DNA between a tadpole and a frog to clone the first animal. Shinya Yamanaka used Gurdon’s concept to turn ordinary skin into potent stem cells. Both won the Nobel Prize for medicine today.
Tokyo Electric Power Co. said the containment chambers of damaged reactors at its Fukushima nuclear plant were likely breached, identifying additional source of radiation leaks that may exceed Chernobyl.
Novartis AG may have violated a Japanese law by promoting its Diovan hypertension medicine as a treatment for cutting stroke risks without sufficient evidence, a breach which could lead to fines and jail terms, according to a government panel.